Study About Antibacterial Soap Part III

Although Batista introduced Levy simply as the director of the Tufts University School of Medicine’s Center for Adaptation Genetics and Drug Resistance and as the author of a book entitled, “The Antibiotic Paradox: How Miracle Drugs Are Destroying the Miracle,” no mention was made of Levy’s affiliation (vice-chairman, chief scientific officer and co-founder) with Paratek Pharmaceuticals.

Paratek was, and, according to its web site, still is working to develop its own antibacterial products for home use — disinfectants that supposedly would “overcome the problems of antibacterial resistance.” The company’s web site states, “Paratek is well positioned to develop [antibacterial] products to serve this non-hospital consumer product market.”

The frenzy over antibacterial products soon died down considerably and the scare has been on the wane ever since. Now Levy’s name is even attached to a long-term study that reports no “supergerm” development in households using triclosan-based antibacterials.

But Levy may not have given up triclosan-bashing altogether. His study concludes with the statement, “However, more extensive and longer term use of triclosan might provide a suitable environment for emergence of resistant species. Further research is needed.”